Clopidogrel bisulfate
- Product NDC
- 68788-9785
- 11-digit product format
- 687889785
- Labeler code
- 68788
- Product ID
- 68788-9785_07cde1a4-52d9-460e-b652-c6be210130b4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clopidogrel bisulfate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA076273
- Marketing category
- ANDA
- Marketing start
- 2012-05-17
- Marketing end
- 0000-00-00
- Substance
- CLOPIDOGREL BISULFATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68788-9785-3 | 2021-02-04 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |
| 68788-9785-6 | 2021-02-04 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |
| 68788-9785-9 | 2021-02-04 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |
| 68788-9785-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |
| 68788-9785-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |
| 68788-9785-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-466b-a910-e053-dadaa90a0b85 | 3e08ca1d-35ef-4b65-9799-5c62c6444d26 |